Erasca, Inc. (ERAS)
NASDAQ·Healthcare·Biotechnology
$14.09
+0.68%
Mkt Cap $4.17B
Analyst Ratings
Buy
11
Hold
1
Sell
0
Price Target (14 analysts)
$11.60
Range $5.00 – $20.00
Implied Upside
-17.7%
Consensus $11.60 vs current $14.09
NASDAQ·Healthcare·Biotechnology
$14.09
+0.68%
Mkt Cap $4.17B
Buy
11
Hold
1
Sell
0
Price Target (14 analysts)
$11.60
Range $5.00 – $20.00
-17.7%
Consensus $11.60 vs current $14.09